Thrombotic microangiopathy in cocaine abuse-associated malignant hypertension: Report of 2 cases with review of the literature

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 12, 2007, Pages 1817-1820

  Gu, Xin ^a   Herrera, Guillermo A ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; COCAINE DEPENDENCE; DISEASE ASSOCIATION; FIBRINOID NECROSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MALIGNANT HYPERTENSION; NECROSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; COCAINE-RELATED DISORDERS; CREATININE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, MALIGNANT; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; THROMBOSIS; VASCULAR DISEASES;

EID: 37349121140     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Nzerue CM, Hewan-Lowe K, Riley LJ. Cocaine and the kidney: a synthesis of pathophysiologic and clinical perspectives. Am J Kidney Dis. 2000,35:783-795.
2. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325-331.
3. Hollander JE, Hoffman RS. Cocaine-induced myocardial infarction: an analysis and review of the literature. J Emerg Med. 1992;10:169-177.
4. Lange RA, Hillis DL. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351-358.
5. Kolodgie FD, Wilson PS, Mergner JW, Virmani R. Cocaine-induced increase in the permeability function of human vascular endothelial cell monolayers. Exp Mol Pathol. 1999;66:109-122.
6. Tacker DH, Okorodudu AO. Evidence for injurious effect of cocaethylene in human microvascular endothelial cells. Clin Chim Acta. 2004;345:66-77.
7. Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103-114.
8. Chokshi SK, Miller G, Rongione A, et al. Cocaine and cardiovascular diseases: the leading age. Cardiology. 1989;III:1-6.
9. Kuhn FE, Johnson MN, Gillis RA, et al. Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs. J Am Coll Cardiol. 1990;16:1481-1491.
10. Pogue VA, Nurse HM. Cocaine-associated acute myoglobinuric renal failure. Am J Med. 1989;87:248-249.
11. Roth D, Alarcon FJ, Fernandez J. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med. 1988;319:673-677.
12. Leblanc M, Hebert MJ, Mongeau JG. Cocaine-induced acute renal failure without rhabdomyolysis. Ann Intern Med. 1994;121:721-722.
13. Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med. 1984;13:1145-1147.
14. Hoffman RS, Henry GC, Howland MA, Weisman RS, Weil L, Goldfrank LR. Association between life-threatening cocaine toxicity and plasma cholinesterase activity. Ann Emerg Med. 1992;21:247-253.
15. Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos. 1989;17:153-159.
16. Merigan KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol. 1987;25:135-148.
17. Menashe PT, Gottlieb JE. Hyperthermia, rhabdomyolysis, and myoglobinuric renal failure after recreational cocaine use. Southern Med J. 1988;81:379-380.
18. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med. 1988;319:673-677.
19. Turbat-Herrera EA, Herrera GA. Cocaine-related acute renal failure without rhabdomyolysis. Pathol Case Rev. 1998;3:210-214.
20. Thakur V, Godley C, Weed S, Cook ME, Hoffman E. Case reports: cocaine-associated accelerated hypertension and renal failure. Am J Med Sci. 1996;312:295-298.
21. Volcy J, Nzerue CM, Oderinde A, Hewan-Iowe K. Cocaine-induced acute renal failure, haemolysis, and thrombocytopenia mimicking thrombotic thrombocytopenic purpura. Am J Kidney Dis. 2000;35:E3.
22. Abd El-Rahman AM, Ammar H. Cocaine-induced acute hepatitis and thrombotic microangiopathy. JAMA. 2005;293:2715-2716.
23. Dlott JS, Danielson CF, Blue-Hnidy DE, McCarthy LJ. Drug-induced thrombotic thrombocytopenic purpura/haemolytic uremic syndrome: a concise review. Ther Apher. 2004;8:102-111.
24. Yarranton H, Machin SJ. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura. Curr Opin Neurol. 2003;16:367-373.
25. Poon J, Van den Buuse M. Autonomic mechanisms in the acute cardiovascular effects of cocaine in conscious rats. Eur J Pharmacol. 1998;363:147-152.
26. Baumann BM, Perrone J, Hornig SE. Randomized controlled double blind placebo controlled trial of diazepam, nitroglycerin or both for treatment of patients with potential cocaine associated acute coronary syndromes. Acad Emerg Med. 2000;7:878-885.
27. Togna G, Tempesta E, Togna AR, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis. 1985;15:100-107.
28. Schnetzer GW III. Platelets and thrombogenesis - current concepts. Am Heart J. 1972;83:552-564.
29. Rezkalla S, Mazza JJ, Kloner RA, et al. The effect of cocaine on human platelets. Am J Cardiol. 1993;72:243-246.
30. Moliterno DJ, Lange RA, Gerard RD, et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med. 1994;96:492-496.
31. Goodman PE, Rennie WP. Renal infarct secondary to nasal insufflation of cocaine. Am J Emerg Med. 1995;13:421-423.
32. Nolte KB. Rhabdomyolysis associated with cocaine abuse. Hum Pathol. 1991;22:1141-1145.